If the Omicron variant of the coronavirus is different enough from the original variant, it’s possible that existing vaccines won’t be as effective as they have been. If so, it’s likely that companies will need to update their vaccines. Deborah Fuller is a microbiologist who has been studying mRNA and DNA vaccines for over two […]
